Evidence map›Paper›PMID 16449502›Full record

ArticleGenome research2006

High-throughput DNA methylation profiling using universal bead arrays.

Marina Bibikova, Zhenwu Lin, Lixin Zhou, Eugene Chudin, Eliza Wickham Garcia, Bonnie Wu, Dennis Doucet, Neal J Thomas, Yunhua Wang, Ekkehard Vollmer and 7 more

Abstract read
In one paragraph

Article in Genome research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 336 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
336citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

336 citing papers in PubMed, 3 syntheses or guidelines pooled it, 672 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Development and validation of MethylCog, a blood DNA methylation proxy for cognition.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

276 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Marina BibikovaIllumina, Inc., San Diego, California 92121, USA.
Zhenwu Lin
Lixin Zhou
Eugene Chudin
Eliza Wickham Garcia
Bonnie Wu
Dennis Doucet
Neal J Thomas
Yunhua Wang
Ekkehard Vollmer
Torsten Goldmann
Carola Seifart
Wei Jiang
David L Barker
Mark S Chee
Joanna Floros
Jian-Bing Fan
Illumina (United States) · US

Funding

High-Throughput Methylation Profiling SystemR44CA097851 · NCI · ILLUMINA, INC. · PI FAN, JIAN-BING · 2004 to 2005
$994k
High-Throughput Methylation Profiling SystemR43CA097851 · NCI · ILLUMINA, INC. · PI FAN, JIAN-BING · 2002 to 2002
$100k
NCI NIH HHS 2 R44 CA097851-02NCI NIH HHS R43 CA097851NCI NIH HHS R44 CA097851PHS HHS R37 NL-34788
6 · The paper itself

Abstract

We have developed a high-throughput method for analyzing the methylation status of hundreds of preselected genes simultaneously and have applied it to the discovery of methylation signatures that distinguish normal from cancer tissue samples. Through an adaptation of the GoldenGate genotyping assay implemented on a BeadArray platform, the methylation state of 1536 specific CpG sites in 371 genes (one to nine CpG sites per gene) was measured in a single reaction by multiplexed genotyping of 200 ng of bisulfite-treated genomic DNA. The assay was used to obtain a quantitative measure of the methylation level at each CpG site. After validating the assay in cell lines and normal tissues, we analyzed a panel of lung cancer biopsy samples (N = 22) and identified a panel of methylation markers that distinguished lung adenocarcinomas from normal lung tissues with high specificity. These markers were validated in a second sample set (N = 24). These results demonstrate the effectiveness of the method for reliably profiling many CpG sites in parallel for the discovery of informative methylation markers. The technology should prove useful for DNA methylation analyses in large populations, with potential application to the classification and diagnosis of a broad range of cancers and other diseases.

Indexed as

DNA FingerprintingDNA MethylationBase SequenceChromosomes, Human, XCpG IslandsGene Expression Regulation, NeoplasticHumansLung NeoplasmsMolecular Sequence DataOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotideReproducibility of ResultsSulfiteshydrogen sulfiteSulfites

Identifiers

PMID16449502
PMCPMC1415217
OpenAlexW2148405421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.